Computational study of the phosphoryl transfer catalyzed by a cyclin-dependent kinase

被引:41
|
作者
De Vivo, Marco
Cavalli, Andrea
Carloni, Paolo
Recanatini, Maurizio
机构
[1] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy
[2] INFM Democritos, I-34014 Trieste, Italy
[3] ISAS, SISSA, Int Sch Adv Studies, I-34014 Trieste, Italy
关键词
density functional calculations; enzymatic catalysis; molecular dynamics; reaction mechanisms; transition state analogues;
D O I
10.1002/chem.200700044
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A cyclin-dependent kinase, Cdk2, catalyzes the transfer of the gamma-phosphate from ATP to a threonine or serine residue of its polypeptide substrates. Here, we investigate aspects of the reaction mechanism of Cdk2 by gas-phase density functional calculations, classical molecular dynamics, and Car-Parrinello QM/MM simulations. We focus on the role of the conserved Asp127 and on the nature of the phosphoryl transfer reaction mechanism catalyzed by Cdk2. Our findings suggest that Asp127 is active in its deprotonated form by assisting the formation of the near-attack orientation of the substrate serine or threonine. Therefore, the residue does not act as a general base during the catalysis. The mechanism for the phosphoryl transfer is a single S(N)2-like concerted step, which shows a phosphorane-like transition state geometry. Although the resulting reaction mechanism is in agreement with a previous density functional study of the same catalytic reaction mechanism (Cavalli et al., Chem. Comm. 2003, 1308-1309), the reaction barrier is considerably lower when QM/MM calculations are performed, as in this study (approximate to 42 kcalmol(-1) QM vs approximate to 24 kcalmol(-1) QM/MM); this indicates that important roles for the catalysis are played by the protein environment and solvent waters. Because of the high amino acid sequence conservation among the whole family of cyclin-dependent kinases (CDKs), these results could be general for the CDK family.
引用
收藏
页码:8437 / 8444
页数:8
相关论文
共 50 条
  • [41] Cyclin-dependent kinase inhibitors in malignant hematopoiesis
    Schirripa, Alessia
    Sexl, Veronika
    Kollmann, Karoline
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] Plant cyclin-dependent kinase inhibitor gene
    Wang, H.
    Fowke, L.C.
    Crosby, W.L.
    Nature, 1997, 386 (6624):
  • [43] Cyclin-dependent kinase homologues of Plasmodium falciparum
    Doerig, C
    Endicott, J
    Chakrabarti, D
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2002, 32 (13) : 1575 - 1585
  • [44] Prediction of Cyclin-Dependent Kinase Phosphorylation Substrates
    Chang, Emmanuel J.
    Begum, Rashida
    Chait, Brian T.
    Gaasterland, Terry
    PLOS ONE, 2007, 2 (08):
  • [45] Cyclin-Dependent Kinase Modulators and Cancer Therapy
    Marialucia Gallorini
    Amelia Cataldi
    Viviana di Giacomo
    BioDrugs, 2012, 26 (6) : 377 - 391
  • [46] Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics
    Law, Mary E.
    Corsino, Patrick E.
    Narayan, Satya
    Law, Brian K.
    MOLECULAR PHARMACOLOGY, 2015, 88 (05) : 846 - 852
  • [47] Regulation of mammalian cyclin-dependent kinase 2
    Sheaff, RJ
    CELL CYCLE CONTROL, 1997, 283 : 173 - 193
  • [48] Cyclin-dependent kinase inhibitors: The age of crystals
    Pines, J
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1332 (01): : M39 - M42
  • [49] Cyclin-dependent kinase 4 inhibitor a and tumor
    Gong, Z.
    Fu, J.
    Chinese Journal of Medical Genetics, 2001, 18 (03) : 219 - 221
  • [50] Cyclin-dependent kinase control of centrosome duplication
    Lacey, KR
    Jackson, PK
    Stearns, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) : 2817 - 2822